Huang YEnzmann VIldstad ST.

Source

Institute for Cellular Therapeutics, University of Louisville, 570 S. Preston Street, Suite 404, Louisville, KY 40202-1760, USA.

Abstract

Retinal degenerative diseases that target photoreceptors or the adjacent retinal pigment epithelium (RPE) affect millions of people worldwide. Retinaldegeneration (RD) is found in many different forms of retinal diseases including retinitis pigmentosa (RP), age-related macular degeneration (AMD), diabetic retinopathy, cataracts, and glaucoma. Effective treatment for retinal degeneration has been widely investigated. Gene-replacement therapy has been shown to improve visual function in inherited retinal disease. However, this treatment was less effective with advanced disease. Stem cell-based therapy is being pursued as a potential alternative approach in the treatment of retinal degenerative diseases. In this review, we will focus onstem cell-based therapies in the pipeline and summarize progress in treatment of retinal degenerative disease.

PMID:20859770[PubMed – indexed for MEDLINE]PMCID:PMC3408315

Can J Ophthalmol. 2010 Aug;45(4):333-41. doi: 10.3129/i10-077.